Dr. Batlevi on the Role of Active Surveillance in Advanced-Stage Follicular Lymphoma

Connie L. Batlevi, MD, PhD, a medical oncologist specializing in lymphoma at Memorial Sloan Kettering Cancer Center, discusses the role of active surveillance in advanced​-stage follicular lymphoma. 

​Patients with advanced​-stage follicular lymphoma ​have disease above and below the diaphragm or cancer ​that has spread beyond the lymph nodes to other parts of the body, says Batlevi. 

After being diagnosed with advanced​-stage disease, patients ​may undergo active surveillance, where they are monitored for about 4 years prior to receiving therapy, ​Batlevi explains.

Notably, a small subset of patients may never require treatment, Batlevi concludes.